TABLE 3.
Hierarchical Linear Modeling of Predictors
| Estimated Coefficient | SE | 95% CI | P | |
|---|---|---|---|---|
| MSEL | ||||
| Intercept | 0.384 | 0.274 | −0.153 to 0.921 | .16 |
| Age | 0.306 | 0.032 | 0.244 to 0.368 | <.001*** |
| Cohort 1–2 | −0.096 | 0.31 | −0.704 to 0.511 | .76 |
| Cohort 2–3 | −0.378 | 0.428 | −1.217 to 0.462 | .38 |
| Age:cohort 1–2 | 0.403 | 0.037 | 0.332 to 0.475 | <.001*** |
| Age:cohort 2–3 | −0.119 | 0.048 | −0.213 to −0.026 | .01* |
| VABS | ||||
| Intercept | −1.72 | 1.489 | −4.639 to 1.198 | .25 |
| Age | 0.513 | 0.039 | 0.437 to 0.589 | <.001*** |
| Cohort 1–2 | 3.28 | 1.683 | −0.018 to 6.579 | .05 |
| Cohort 2–3 | 2.054 | 2.385 | −2.621 to 6.729 | .39 |
| Age:cohort 1–2 | 0.281 | 0.049 | 0.186 to 0.377 | <.001*** |
| Age:cohort 2–3 | −0.219 | 0.074 | −0.365 to −0.073 | .003** |
| PLS | ||||
| Intercept | 1.369 | 2.241 | −3.023 to 5.761 | .54 |
| Age | 0.935 | 0.068 | 0.801 to 1.068 | <.001*** |
| Cohort 1–2 | 2.718 | 2.501 | −2.183 to 7.619 | .28 |
| Cohort 2–3 | −0.955 | 3.479 | −7.773 to 5.863 | .78 |
| Age:cohort 1–2 | 0.263 | 0.075 | 0.116 to 0.410 | <.001*** |
| Age:cohort 2–3 | −0.234 | 0.115 | −0.460 to −0.008 | .04* |
| LEAQ | ||||
| Intercept | 1.514 | 1.02 | −0.486 to 3.513 | .14 |
| Age | 0.268 | 0.041 | 0.188 to 0.347 | <.001*** |
| Cohort 1–2 | −0.668 | 1.15 | −2.923 to 1.587 | .56 |
| Cohort 2–3 | −1.283 | 1.588 | −4.396 to 1.830 | .42 |
| Age:cohort 1–2 | 0.166 | 0.049 | 0.071 to 0.261 | <.001*** |
| Age:cohort 2–3 | −0.243 | 0.061 | −0.363 to –0.124 | <.001*** |
| PSI | ||||
| Intercept | 61.561 | 10.622 | 40.742 to 82.380 | <.001*** |
| Age | 3.005 | 0.283 | 2.450 to 3.561 | <.001*** |
| Cohort 1–2 | −7.356 | 11.998 | −30.872 to 16.160 | .54 |
| Cohort 2–3 | −33.579 | 17.142 | −67.177 to 0.019 | .05 |
| Age:cohort 1–2 | 0.357 | 0.356 | −0.341 to 1.055 | .32 |
| Age:cohort 2–3 | 1.328 | 0.572 | 0.208 to 2.448 | .02* |
Cohort 1, normal cognitive skills and adaptive behavior, underwent cochlear implantation, not lost to follow-up (n = 99); cohort 2, EDI, underwent cochlear implantation, not lost to follow-up (n = 32); cohort 3, EDI, hearing aids only, not lost to follow-up (n = 29); cohort 1–2 and cohort 2–3, cohort 2 is the baseline, cohorts 1 and cohort 3 compared against it; and age:cohort 1–2 and age:cohort 2–3, interaction between age and cohorts 1–2 or cohorts 2–3.
P < .05,
P < .01,
P < .001.